Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
BleauGenics Retatrutide is a high-purity investigational polypeptide presented in lyophilized powder form for laboratory research use
10.1021/jm4017448 23 HendersonS
Supplementary Table 7
On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said
While originally developed to treat Type 2 diabetes, these medications are now frequently prescribed for chronic weight management in the UK, provided the patient meets specific criteria regarding Body Mass Index (BMI) and weight-related health conditions
In contrast, the exposed rats exhibited changes in the form of inflammatory cell infiltrate, and the remaining exposed rats displayed a liver morphology within normal limits (Table 1)
